2023-03-26 15:19:01
Latest Post
Zydus Lifesciences Ltd gets 3 observations from USFDA for Pharmex, Ahmedabad facility
Lupin announces Successful Completion of UK MHRA Inspection of its Pithampur Facilities
Kalyan Jewellers' brand ambassador Rashmika Mandanna inaugurates showroom at Vaishali Nagar, Jaipur
Motisons Jewellers files DRHP for IPO
PM inaugurates the RuPay National Common Mobility Card for Bangalore Metro with RBL Bank as Issuing Bank
Stock Report
Nureca Ltd Q3 FY2023 consolidated net profit at Rs. 30.1 lakhs
Posted On : 2023-02-04 00:19:24( TIMEZONE : IST )
Nureca Limited has reported Consolidated financial results for the period ended December 31, 2022.
Financial Results (Q3 FY2023) - QoQ Comparison
The company has reported total income of Rs. 29.684 crores during the period ended December 31, 2022 as compared to Rs. 38.671 crores during the period ended September 30, 2022.
The company has posted net profit / (loss) of Rs. 0.301 crores for the period ended December 31, 2022 as against net profit / (loss) of Rs. -2.892 crores for the period ended September 30, 2022.
The company has reported EPS of Rs. 0.30 for the period ended December 31, 2022 as compared to Rs. -2.89 for the period ended September 30, 2022.
| Financials | Q3 FY2023 | Q2 FY2023 | % Change |
| Total Income | ₹29.684 crs | ₹38.671 crs |  -23.24% |
| Net Profit | ₹0.301 crs | ₹-2.892 crs |  110.41% |
| EPS | ₹0.30 | ₹-2.89 | 110.38% |
Financial Results (Q3 FY2023) - YoY Comparison
The company has reported total income of Rs.29.684 crores during the period ended December 31, 2022 as compared to Rs.49.813 crores during the period ended December 31, 2021.
The company has posted net profit / (loss) of Rs.0.301 crores for the period ended December 31, 2022 as against net profit / (loss) of Rs.4.734 crores for the period ended December 31, 2021.
The company has reported EPS of Rs.0.30 for the period ended December 31, 2022 as compared to Rs.4.73 for the period ended December 31, 2021.
| Financials | Q3 FY2023 | Q3 FY2022 | % Change |
| Total Income | ₹29.684 crs | ₹49.813 crs | -40.41% |
| Net Profit | ₹0.301 crs | ₹4.734 crs | -93.64% |
| EPS | ₹0.30 | ₹4.73 | -93.66% |
Financial Results (9 Months Ended FY2023) - YoY Comparison
The company has reported total income of Rs.95.054 crores during the 9 Months period ended December 31, 2022 as compared to Rs.220.484 crores during the 9 Months period ended December 31, 2021.
The company has posted net profit / (loss) of Rs.-6.720 crores for the 9 Months period ended December 31, 2022 as against net profit / (loss) of Rs.46.364 crores for the 9 Months period ended December 31, 2021.
The company has reported EPS of Rs.-6.72 for the 9 Months period ended December 31, 2022 as compared to Rs.46.36 for the 9 Months period ended December 31, 2021.
| Financials | 9 Months Ended FY2023 | 9 Months Ended FY2022 | % Change |
| Total Income | ₹95.054 crs | ₹220.484 crs | -56.89% |
| Net Profit | ₹-6.720 crs | ₹46.364 crs | -114.49% |
| EPS | ₹-6.72 | ₹46.36 | -114.50% |
Shares of Nureca Limited was last trading in BSE at Rs. 380.85 as compared to the previous close of Rs. 392.90. The total number of shares traded during the day was 8481 in over 808 trades.
The stock hit an intraday high of Rs. 404.95 and intraday low of 373.10. The net turnover during the day was Rs. 3243236.00.
